Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Equity (2016 - 2025)

Corcept Therapeutics' Return on Equity history spans 10 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Equity fell 6.0% year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, down 6.0%, while the annual FY2025 figure was 0.15%, 9.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.16% at Corcept Therapeutics, down from 0.17% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.29% in Q1 2022 and bottomed at 0.16% in Q4 2025.
  • The 5-year median for Return on Equity is 0.21% (2022), against an average of 0.21%.
  • The largest annual shift saw Return on Equity increased 9bps in 2022 before it fell -10bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.25% in 2021, then decreased by -15bps to 0.21% in 2022, then increased by 5bps to 0.22% in 2023, then decreased by -2bps to 0.21% in 2024, then decreased by -27bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for CORT's Return on Equity are 0.16% (Q4 2025), 0.17% (Q3 2025), and 0.2% (Q2 2025).